Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 18.2483.21-18.9040.1821.22

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is 18.24 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar202618.24
Mar202583.21
Mar2024-18.90
Mar202340.18
Mar202221.22

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 18.24
-78.08
Mar2025 83.21
Positive
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,590.6 Cr -0% 1.4% 1.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹111,888.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

-0%

1.4%

1.2%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses